With a medicine on the market and plenty of projects in the pipeline, this company's trajectory could be very positive for ...

Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR ...

Nabsys 2.0, LLC ("Nabsys"), a pioneer in Electronic Genome Mapping (EGM), today announced the publication of a new preprint ...

CRISPR may be a powerful technology for gene editing, but the system existed in bacteria long before scientists began using it. For billions of years, CRISPR has acted as a natural immune system in ...

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

In a Phase 1 Cleveland Clinic trial, a single infusion of an experimental gene editing therapy called CTX310 cut bad LDL ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as ...

Crispr stock, alongside other gene-editing equities, pulled a bullish move Thursday — bounding for a breakout from a cup-with ...

With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and ...

Mississippi awarded more than $104 million in federal rural health grants across 167 projects. Where the money goes and why rural access matters. Community paramedics in rural Virginia visit patients ...